Through strategic partnerships similar to the Pharmalink agreement, the medication has already reached patients in China, Hong Kong, Japan, and various Latin American markets.
The surgery combined breast augmentation with bilateral brachioplasty—a procedure that removes excess skin from both arms—to restore natural contours and enhance symmetry.
The formal signing ceremony brought together key stakeholders from both organizations, with Dr. Hanan Al Suwaidi representing Dubai Health and Prosun Niyogi signing on behalf of Johnson & Johnson MedTech, while Dr. Tarek Fathey attended as a witness to this landmark healthcare partnership.
This step supports the UAE’s goals to bolster national readiness, secure pharmaceutical supplies, and guarantee steady access to medicines nationwide.
Almond Blossoms provides a full range of fertility services, including IVF, ICSI, IUI, egg and sperm freezing, genetic testing, fertility assessments, and individualized reproductive planning.
The rebrand responds to growing scientific understanding that metabolic syndrome functions as a multi-system condition rather than isolated diseases.
EHS has become the first public health system in the UAE to implement a multi-agentic AI clinical intelligence platform.
The partnership seeks to create a more connected, innovation-driven healthcare landscape that aligns with the UAE’s vision for building a diversified, knowledge-based economy.
The institute brings together a team of internationally trained cardiologists and heart specialists who offer complete care spanning prevention, early detection, complex procedures, and ongoing disease management.
Dr. Ali has served as a board member of Amanat Holdings since November 2020, bringing more than twenty years of expertise in education and business development.